Today: 1 May 2026
Browse Category

NYSE:UNH 5 January 2026 - 15 January 2026

UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth shares rose 0.3% to $334.96 in after-hours trading after its UnitedHealthcare unit launched a pilot to speed Medicare Advantage payments to rural hospitals. The move comes as a Senate committee report accuses UnitedHealth of inflating reimbursements through aggressive coding, which the company disputes. Investors await UnitedHealth’s 2026 outlook on Jan. 27.
15 January 2026
·
UnitedHealth stock jumps as insurer speeds Medicare Advantage payments for rural hospitals

UnitedHealth stock jumps as insurer speeds Medicare Advantage payments for rural hospitals

UnitedHealth Group shares rose 1.7% to $339.53 midday Wednesday after its UnitedHealthcare unit announced a pilot to speed Medicare Advantage payments to rural hospitals. The move follows a Senate report accusing UnitedHealth of aggressive billing, which the company disputes. Executives plan to reaffirm 2025 earnings targets in upcoming investor calls. Full-year 2025 results and 2026 outlook are due Jan. 27.
14 January 2026
·
Healthcare stocks face JPMorgan conference pressure as XLV slips and deal talk builds

Healthcare stocks face JPMorgan conference pressure as XLV slips and deal talk builds

U.S. healthcare stocks fell this week, with the XLV ETF down 0.5% to $157.31, even as the S&P 500 hit a record high. Two biotech firms, Eikon Therapeutics and Veradermics, filed for IPOs. Healthcare M&A value rose 56% in 2025 to $403 billion, despite fewer deals. Insmed reported preliminary 2025 ARIKAYCE sales of $433.8 million and set a 2026 revenue target of $450–470 million.
10 January 2026
···
UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

UnitedHealth shares fell 0.8% to $343.98 Friday as senators widened their probe into the company’s nursing-home programs, citing unsatisfactory responses. Lawmakers warned they may escalate pressure if UnitedHealth does not cooperate. The company’s earnings call is set for Jan. 27. Investors are also awaiting the Jan. 13 consumer price index data.
10 January 2026
··
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House committees summoned UnitedHealth and four other insurers to testify on coverage affordability Jan. 22. UnitedHealth shares rose 1.5% to $346.85 after Wolfe Research raised its price target to $400. The company reports 2025 earnings and 2026 guidance Jan. 27. Senators also accused UnitedHealth of withholding documents in a nursing home care probe.
9 January 2026
·····
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth shares rose 1.3% to $346.11 after U.S. House lawmakers called major health insurer CEOs to testify on coverage affordability January 22. Senators Wyden and Warren accused UnitedHealth of withholding documents in a nursing-home probe, setting a January 28 deadline. TPG is in advanced talks to buy UnitedHealth’s Optum UK unit for up to £1.4 billion, Sky News reported.
8 January 2026
····
UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth Group shares fell 2% to $341.70 in after-hours trading Wednesday, following a late-session slide. The drop came as investors weighed a possible Optum UK sale to TPG for up to $1.89 billion and awaited the company’s Jan. 27 earnings report. Peers Cigna, CVS Health, and Elevance Health also declined. U.S. job openings hit a 14-month low, further pressuring market sentiment.
7 January 2026
··
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
7 January 2026
·······
UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

UnitedHealth Group shares rose 2% to $348.97 Tuesday after Sky News reported TPG is nearing a deal to buy the insurer’s Optum UK unit for up to £1.4 billion. The report comes weeks before UnitedHealth’s Jan. 27 earnings, where it will give 2026 guidance. Talks remain tentative, with Bank of America advising and other firms interested. Optum UK includes EMIS, acquired for £1.24 billion and cleared by UK regulators in 2023.
7 January 2026
··
Dow Jones today: Record highs hold as investors brace for Friday jobs report

Dow Jones today: Record highs hold as investors brace for Friday jobs report

The Dow Jones Industrial Average rose 0.9% Tuesday, nearing the 50,000 mark, led by gains in UnitedHealth and Amazon. S&P 500 and Nasdaq each added about 0.5%. Traders looked ahead to Friday’s U.S. jobs report for signals on Federal Reserve rate moves. Richmond Fed President Thomas Barkin said future rate changes will depend on incoming data.
6 January 2026
·····
UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth Group shares rose 2.1% to $349.25 after reports TPG neared a deal to buy its Optum UK unit, valuing the business at up to £1.4 billion. The move boosted the Dow, with UnitedHealth and Amazon contributing 87 points to a 218-point gain. The company will report full-year 2025 results and 2026 guidance on Jan. 27. The Optum UK sale is not finalized and could still fall through.
6 January 2026
··
UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth shares rose 1.7% to $342.02 Monday after Barclays raised its price target to $391 and reaffirmed an Overweight rating. The move came as investors positioned ahead of UnitedHealth’s Jan. 27 earnings and 2026 guidance. The stock traded between $333.86 and $346.83 on volume of 7.9 million shares. UnitedHealth remains well below its 52-week high of $606.36.
6 January 2026
··
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth shares rose 0.8% to $338.94 in late-morning trading Monday after Barclays raised its price target to $391 and reiterated an Overweight rating. Investors are watching ahead of Jan. 27, when UnitedHealth will report 2025 results and 2026 guidance. Scrutiny remains on medical-cost trends, operational review progress, and ongoing Justice Department investigations into Medicare Advantage billing.
5 January 2026
·····
1 … 3 4 5 6 7 … 9

Stock Market Today

  • Cardano (ADA) Prospects: Governance Focus and Potential for Millionaire Returns
    April 30, 2026, 10:39 PM EDT. Cardano (ADA), a governance-focused cryptocurrency launched in 2017 by Ethereum co-founder Charles Hoskinson, once soared to $3.10 but now trades near $0.25. It uses an energy-efficient proof-of-stake blockchain, Ouroboros, enabling faster transaction speeds than Ethereum and requiring rigorous peer reviews for projects to enhance security and scalability. Despite this, its developer community remains small compared to Ethereum's. Cardano's unique governance approach and new features like the Midnight sidechain could attract regulated industries. However, to turn $10,000 into $1 million again, ADA's price must rise 100-fold to $25, pushing its market cap beyond Ethereum but below Bitcoin's. The path to such growth faces significant challenges amid market competition and adoption hurdles.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop